Myelin–Axon Interface Vulnerability in Alzheimer’s Disease Revealed by Subcellular Proteomics and Imaging of Human and Mouse Brain
7 Articles
7 Articles
Myelin–axon interface vulnerability in Alzheimer’s disease revealed by subcellular proteomics and imaging of human and mouse brain
Myelin ensheathment is essential for rapid axonal conduction, metabolic support and neuronal plasticity. In Alzheimer’s disease (AD), disruptions in myelin and axonal structures occur, although the underlying mechanisms remain unclear. We implemented proximity labeling subcellular proteomics of the myelin–axon interface in postmortem human brains from AD donors and 15-month-old male and female 5XFAD mice. We uncovered multiple dysregulated signa…
High-resolution images reveal similarities in protein structures between Alzheimer's disease and Down syndrome
More than 90% of people with Down syndrome, the most common chromosomal disorder in humans and the most frequent genetic cause of intellectual disability, are diagnosed with Alzheimer's disease by ages 55–60.
To Understand Alzheimer’s Disease, Researchers Turn to Myelin Sheath
The disruption of axons—the thread-like part of nerve cells that transmits electrical signals—is associated with Alzheimer’s disease. One way axonal function may be hindered is through damage to the myelin sheath, a fatty coating that wraps around axons. Similar to the plastic or rubber used to insulate a cable, the my...
Rewrite Myelin–axon interface vulnerability in Alzheimer’s disease
Myelin ensheathment is essential for rapid axonal conduction, metabolic support and neuronal plasticity. In Alzheimer’s disease (AD), disruptions in myelin and axonal structures occur, although the underlying mechanisms remain unclear. We implemented proximity labeling subcellular proteomics of the myelin–axon interface in postmortem human brains from AD donors and 15-month-old male and female 5XFAD mice. We uncovered multiple dysregulated signa…
A study led by the Sant Pau Research Institute (IR Sant Pau) has revealed that the loss of...
The results, published in Brain magazine, reveal that the loss of volume and cortical thickness in these regions can begin between 13 and 15 years before the onset of symptoms, representing a significant advance in the field of early diagnosis and the design of preventive clinical trials of Alzheimer's in Down syndrome. The study is based on a large cohort of 259 adults with Down syndrome and 138 euploid controls (people without Down syndrome), …
Coverage Details
Bias Distribution
- 100% of the sources are Center
To view factuality data please Upgrade to Premium